Modified Nucleosides
4'-alpha-C-Allyl-2',3'-bis-O-(tert-butyldimethylsilyl)uridine
Quick view. A 4'-C-allyl uridine derivative with tert-butyldimethylsilyl protection at the 2'- and 3'-oxygen positions. CAS 512184-18-8. Catalog target purity: ≥98%. Availability: Inquiry only — contact BX Lab to confirm current availability.
Product profile
4'-alpha-C-Allyl-2',3'-bis-O-(tert-butyldimethylsilyl)uridine is classified as 4'-c-allyl, 2',3'-bis-o-tbdms uridine derivative (Formula C24H44N2O6Si2; molecular weight 512.80 g/mol).
4'-alpha-C-Allyl-2',3'-bis-O-(tert-butyldimethylsilyl)uridine is associated with cytosine-containing building blocks or substrates for C-position incorporation and analytical comparison.
For 4'-alpha-C-Allyl-2',3'-bis-O-(tert-butyldimethylsilyl)uridine, confirm the current specification, storage conditions and downstream-method compatibility before routine use.
Names and search terms
Useful catalog search terms
- 512184-18-8
- KGAPLZBTUZPPLY-ZBNTXBBCSA-N
Physicochemical data
| PubChem CID | 11420900 |
|---|---|
| IUPAC name | 1-[(2R,3R,4S,5R)-3,4-bis[[tert-butyl(dimethyl)silyl]oxy]-5-(hydroxymethyl)-5-prop-2-enyloxolan-2-yl]pyrimidine-2,4-dione |
| InChIKey | KGAPLZBTUZPPLY-ZBNTXBBCSA-N |
| InChI | InChI=1S/C24H44N2O6Si2/c1-12-14-24(16-27)19(32-34(10,11)23(5,6)7)18(31-33(8,9)22(2,3)4)20(30-24)26-15-13-17(28)25-21(26)29/h12-13,15,18-20,27H,1,14,16H2,2-11H3,(H,25,28,29)/t18-,19+,20-,24-/m1/s1 |
| SMILES | CC(C)(C)[Si](C)(C)O[C@@H]1[C@@H]([C@@](O[C@H]1N2C=CC(=O)NC2=O)(CC=C)CO)O[Si](C)(C)C(C)(C)C |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Related products
(S)-cEt-rA
Modified Nucleosides · CAS: 1197033-34-3
BX-OP-0069S-Adenosyl-L-methionine (SAM)
Modified Nucleosides · CAS: 485-80-3
BX-MN-01875-(Carboxyhydroxymethyl)uridine
Modified Nucleosides · CAS: 934743-11-0
BX-MN-0719(R)-N6-(2,3-Dihydro-1H-inden-1-yl)adenosine
Modified Nucleosides · CAS: 96392-15-3
BX-MN-01972,2'-Cyclocytidine hydrochloride
Modified Nucleosides · CAS: 10212-25-6
BX-MN-0199N3-Allyluridine
Modified Nucleosides · CAS: 103951-13-9
Frequently asked questions
Can the package size for 4'-alpha-C-Allyl-2',3'-bis-O-(tert-butyldimethylsilyl)uridine be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-MN-0574 and CAS 512184-18-8, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
These publications provide peer-reviewed context for the Modified Nucleosides product family and its named chemistry. They are background reading only, not evidence for the exact product, supplied form, lot specification, availability or performance.
Technology platforms
Catalog-derived platform membership for navigating related chemistry and verifiable product sets.